Will new higher-precision troponins lead to clarity or confusion?

Current Opinion in Cardiology

Volumn 23, Issue 4, 2008, Pages 292-295

  White, Harvey D ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

High precision troponins; Myocardial infarction; Prognosis

Indexed keywords

TROPONIN;

ACCURACY; ACUTE CORONARY SYNDROME; HEART FAILURE; HEART INFARCTION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN;

EID: 44649149055     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283050808     Document Type: Review

References (29)

1. White HD. Evolution of the definition of myocardial infarction: what are the implications of a new universal definition? Heart 2008; 94:679-684.
2. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint EuropeanSociety of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36:959-969.
3. Apple FS, Quist HE, Doyle PJ, et al. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49:1331-1336.
4. Panteghini M, Pagani F, Yeo KT, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004; 50:327-332.
5. Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007; 53:1558-1560.
6. Christenson RH, Cervelli DR, Bauer RS, et al. Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations. Clin Biochem 2004; 37:679-683.
7. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007; 128:282-286. This study shows that new troponin I assay can detect troponin elevation earlier enabling earlier triage of patients with an acute coronary syndrome.
8. Roger VL, Killian JM, Weston SA, et al. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation 2006; 114:790-797.
9. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50:2173-2195. A new universal definition of MI using troponin assays as cornerstone of definition.
10. Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007; 28:1242-1249. A study reporting MI diagnosed by MRI despite normal coronary arteries.
11. White HD. Things ain't what they used to be: impact of a new definition of myocardial infarction [editorial]. Am Heart J 2002; 144:933-937.
12. Goodman SG, Steg PG, Eagle KA, et al. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006; 151:654-660.
13. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003; 115:178-184.
14. Eggers KM, Lagerqvist B, Venge P, et al. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007; 116:1907-1914. This study shows 5-year prognostic value of a higher-precision troponin assay with detection of elevated levels in a third of patients at 6 months.
15. Okamatsu K, Takano M, Sakai S, et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation 2004; 109:465-470.
16. Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 2002; 106:202-207.
17. Dokainish H, Pillai M, Murphy SA, et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005; 45:19-24.
18. Jaffe AS. Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 2006; 48:1763-1764.
19. Le EH, Klootwijk PJ, Weimar W, et al. Significance of acute versus chronic troponin T elevation in dialysis patients. Nephron Clin Pract 2004; 98:c87-c92.
20. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006; 113:1071-1078.
21. Melanson SEF, Tanasijevic MJ, Jarolim P. Cardiac troponin assays: a view from the clinical chemistry laboratory. Circulation 2007; 116:e501-e504.
22. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113:1958-1965.
23. Wu AH, Fukushima N, Puskas R, et al. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006; 52:2157-2159.
24. Latini R, Masson S, Anand IS, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007; 116:1242-1249. The first study showing that high-precision troponin assays are prognostically important in heart failure.
25. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004; 90:99-106.
26. Apple FS, Smith SW, Pearce LA, et al. Use of the centaur TnI-ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008; 54:723-728.
27. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation 1999; 100:1593-1601.
28. Kastrati A, Mehilli J, Neumann FJ, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006; 295:1531-1538.
29. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879-1887.